These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25875690)

  • 41. Health Literacy and Success with Glaucoma Drop Administration.
    Kang JM; Chatterjee A; Rosdahl JA; Bosworth HB; Woolson S; Olsen M; Sexton M; Kirshner M; Muir KW
    Ophthalmol Glaucoma; 2022; 5(1):26-31. PubMed ID: 34052458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Glaucoma and dry eye. Current concepts and future perspectives].
    Steven P; Cursiefen C
    Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Social and Health Care Utilization Factors Associated With Ophthalmic Visit Nonadherence in Glaucoma: An All of Us Study.
    Wu JH; Varkhedi V; Radha Saseendrakumar B; Acuff K; Weinreb RN; Baxter SL
    J Glaucoma; 2023 Dec; 32(12):1029-1037. PubMed ID: 37671531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment patterns and medication adherence of patients with glaucoma in South Korea.
    Kim CY; Park KH; Ahn J; Ahn MD; Cha SC; Kim HS; Kim JM; Kim MJ; Kim TW; Kim YY; Lee JW; Park SW; Sohn YH; Sung KR; Yoo C; Cha J; Kim YJ
    Br J Ophthalmol; 2017 Jun; 101(6):801-807. PubMed ID: 28270490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
    Beckers HJ; Webers CA; Busch MJ; Brink HM; Colen TP; Schouten JS;
    Acta Ophthalmol; 2013 Nov; 91(7):610-8. PubMed ID: 23025424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey.
    Moore DB; Walton C; Moeller KL; Slabaugh MA; Mudumbai RC; Chen PP
    BMC Ophthalmol; 2014 Jun; 14():79. PubMed ID: 24927769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A video study of drop instillation in both glaucoma and retina patients with visual impairment.
    Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
    Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glaucoma medication adherence among African Americans: program development.
    Dreer LE; Girkin CA; Campbell L; Wood A; Gao L; Owsley C
    Optom Vis Sci; 2013 Aug; 90(8):883-97. PubMed ID: 23873033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
    Loon SC; Jin J; Jin Goh M
    J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferences for eye drop characteristics among glaucoma specialists: a willingness-to-pay analysis.
    Jampel HD; Parekh P; Johnson E; Robin AL; Miller RB
    J Glaucoma; 2005 Apr; 14(2):151-6. PubMed ID: 15741818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
    Sanchez FG; Mansberger SL; Newman-Casey PA
    J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.
    Killeen OJ; MacKenzie C; Heisler M; Resnicow K; Lee PP; Newman-Casey PA
    J Glaucoma; 2016 Oct; 25(10):815-821. PubMed ID: 27096721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication Adherence Among Patients With Corneal Diseases.
    Khan M; Michelson S; Newman-Casey PA; Woodward MA
    Cornea; 2021 Dec; 40(12):1554-1560. PubMed ID: 33661137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient satisfaction with topical ocular hypotensives.
    Kerr NM; Patel HY; Chew SS; Ali NQ; Eady EK; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2013; 41(1):27-35. PubMed ID: 22594958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-related nonadherence with glaucoma medications in Ontario.
    Buys YM; Kagan D; Jin YP; Trope GE
    Can J Ophthalmol; 2021 Dec; 56(6):379-384. PubMed ID: 33548175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of glaucoma medications: state of the science and directions for observational research.
    Lu VH; Goldberg I; Lu CY
    Am J Ophthalmol; 2010 Oct; 150(4):569-574.e9. PubMed ID: 20678750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.